Development of a tRNA-derived small RNA diagnostic and prognostic signature in liver cancer

Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Canc, 136, E359, 10.1002/ijc.29210 McGlynn, 2015, Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability, Clin Liver Dis, 19, 223, 10.1016/j.cld.2015.01.001 Medavaram, 2018, Emerging therapies in advanced hepatocellular carcinoma, Exp Hematol Oncol, 7, 17, 10.1186/s40164-018-0109-6 Tsochatzis, 2013, Transarterial chemoembolisation is not superior to embolisation alone: the recent European Association for the Study of the Liver (EASL) - European Organisation for Research and Treatment of Cancer (EORTC) guidelines, Eur J Cancer, 49, 1509, 10.1016/j.ejca.2012.11.012 Chong, 2013, Rising incidence of primary liver cancer in Brunei Darussalam, Asian Pac J Cancer Prev, 14, 3473, 10.7314/APJCP.2013.14.6.3473 Golabi, 2017, Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities, Medicine, 96, e5904, 10.1097/MD.0000000000005904 Haussecker, 2010, Human tRNA-derived small RNAs in the global regulation of RNA silencing, RNA, 16, 673, 10.1261/rna.2000810 Lee, 2009, A novel class of small RNAs: tRNA-derived RNA fragments (tRFs), Genes Dev, 23, 2639, 10.1101/gad.1837609 Yamasaki, 2009, Angiogenin cleaves tRNA and promotes stress-induced translational repression, J Cell Biol, 185, 35, 10.1083/jcb.200811106 Balatti, 2017, tsRNA signatures in cancer, Proc Natl Acad Sci U S A, 114, 8071, 10.1073/pnas.1706908114 Yang, 2017, Recurrently deregulated lncRNAs in hepatocellular carcinoma, Nat Commun, 8, 14421, 10.1038/ncomms14421 Liu, 2021, Small noncoding RNA discovery and profiling with sRNAtools based on high-throughput sequencing, Briefings Bioinformat, 22, 463, 10.1093/bib/bbz151 Martin, 2011, Cutadapt removes adapter sequences from high-throughput sequencing reads, EMBnet J, 17, 10, 10.14806/ej.17.1.200 Wei, 2018, Missing value imputation approach for mass spectrometry-based metabolomics data, Sci Rep., 8, 663, 10.1038/s41598-017-19120-0 Vlachos, 2015, DIANA-miRPath v3. 0: deciphering microRNA function with experimental support, Nucleic Acids Res, 43, W460, 10.1093/nar/gkv403 Genuer, 2010, Tuleau-malot CJPrl. Variable selection using random forests, Pattern Recognit Lett, 31, 2225, 10.1016/j.patrec.2010.03.014 Tibshirani, 1996, Regression shrinkage and selection via the lasso, J Royal Stat Soc, 58, 267 Weng, 2017, Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer, Transl Res, 181, 108, 10.1016/j.trsl.2016.10.001 Zhu, 2019, Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis, Mol Cancer, 18, 74, 10.1186/s12943-019-1000-8 Jin, 2019, Emerging role of a novel small non-coding regulatory RNA: tRNA-derived small RNA, ExRNA, 1, 39, 10.1186/s41544-019-0036-7 Vychytilova-Faltejskova, 2017, MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9, Oncogen esis, 6, 1 Liu, 2020, miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway, J Cell Biochem, 121, 1475, 10.1002/jcb.29383 Zhao, 2019, miR-192/215-5p act as tumor suppressors and link Crohn's disease and colorectal cancer by targeting common metabolic pathways: An integrated informatics analysis and experimental study, J Cell Physiol, 234, 21060, 10.1002/jcp.28709 Pan, 2020, miR-210 participates in hepatic ischemia reperfusion injury by forming a negative feedback loop with SMAD4, Hepatology, 72, 2134, 10.1002/hep.31221 Ji, 2018, Up-regulation of hsa-miR-210 promotes venous metastasis and predicts poor prognosis in hepatocellular carcinoma, Front Oncol, 8, 569, 10.3389/fonc.2018.00569 Epis, 2014, miR-331-3p regulates expression of neuropilin-2 in glioblastoma, J Neuro-oncol, 116, 67, 10.1007/s11060-013-1271-7 Xie, 2018, MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma, Oncol Lett, 15, 4571 Meng, 2017, Downregulation of miR-33a-5p in hepatocellular carcinoma: a possible mechanism for chemotherapy resistance, Med Sci Monit, 23, 1295, 10.12659/MSM.902692 Tang, 2018, Fatty acid activation in carcinogenesis and cancer development: Essential roles of long-chain acyl-CoA synthetases, Oncol Lett, 16, 1390 Montagner, 2019, β-catenin oncogenic activation rewires fatty acid catabolism to fuel hepatocellular carcinoma, Gut, 68, 183, 10.1136/gutjnl-2018-316557